Mishra Dhatu Nigam Limited has informed the Exchange about cessation of Anurag Bajpai as Nominee Director of the company w.e.f. 10-Nov-2022
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are enclosing herewith the Revised Investor Presentation for Q2H1FY23.We would like to inform yo that the following changes have been made in Investors presentation :-1. Slide No - 7 -- CARBON FOOT PRINT REDUCTION GPIL- KHAIRAGARH- 25 MW (earlier it was inadvertently mentioned as 38 MW)2. Slide No - 30 - DETAILED REALISATION SUMMARY Iron Ore Pellet- GPIL - H1 23 Column - Rs.9,671 (earlier it was inadvertently mentioned as Rs.7,082)There is no other change in attached presentation .The copy of revised presentation is also being hosted on the website of the company viz., www.godawaripowerispat.com. The said presentation will also be shared with Analysts/investors.
Pursuant to Regulation 30 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that Mr. Shiv Ram Singh, Company Secretary & Compliance Officer (KMP) has resigned from the position with effect from the close of business hours on November 15, 2022
KRBL Limited has informed the Exchange about Investor Presentation on Unaudited Financial Results of KRBL Limited for the SecondQuarter (Q2) and Half Year ended 30 September 2022
Natco Pharma Limited has informed the Exchange about Investor Presentation
Adani Power Limited has informed the Exchange about resignation of Ms. Gauri Trivedi as an Independent Director of the company w.e.f. 12-Nov-2022
POWERGRID Infrastructure Investment Trust has informed the Exchange about Investor Presentation
JSW Steel Limited has informed the Exchange about press release dated 11-Nov-2022 titled Crude Steel Production for Oct???22 grew by 25% YoY.
Healthcare Global Enterprises Limited has informed the Exchange about press release dated 10-Nov-2022 titled Financial Results of the Company for the quarter and half year ended September 30, 2022
AstraZeneca Pharma India Limited has informed the Exchange about Board Meeting held on 11-Nov-2022 to consider financial statements for the period ended September 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
